Is Merrimack Pharmaceuticals Inc (MACK) A Good Stock To Buy?
Looking for high-potential stocks? Just follow the big players within the hedge fund industry.
Merrimack Pharmaceuticals Inc (MACK)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
5 Stocks Hedge Funds Hate The Most
Insider Monkey keeps a keen eye on the activity of the top hedge funds in the world, as our research has shown that hedge funds’ long positions can deliver market-beating returns.
Merrimack Pharmaceuticals Inc (MACK) Sees Earnings Boost As FDA Accepts Application For Generic Drug
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) have moved closer to introducing their generic version of Johnson & Johnson (NYSE:JNJ) drug DOXIL to...
Here's Why TASER International, Heron Therapeutics and Three Other Stocks Are Trading Lower on Monday
The markets have opened the fourth quarter on a negative note.
What Is Going On With These Falling Stocks?
After opening flat and falling into the red, the broader markets are now in the green this afternoon as investors weigh the overall positive start to earnings season.
Do Hedge Funds Love Merrimack Pharmaceuticals Inc (MACK)?
Hedge funds are not perfect. They have their bad picks just like everyone else. Micron, a stock hedge funds have loved, lost 50% during the last 12 months ending in October 30.
Hedge Funds Have This To Say About Tuesday's Healthcare Flops
Tuesday was a bad day for three healthcare stocks in particular.
Should You Buy Merrimack Pharmaceuticals Inc (MACK) After The 10% Surge?
Should you buy Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock today? The firm’s share price surged 10.22% on June 18 to attain a closing price of $12.19 after a heavy volume day.
Two Directors at Merrimack Pharmaceuticals Inc (MACK) Acquired Almost Half a Million in Stock
June 23, two Board Directors at Merrimack Pharmaceuticals Inc (NASDAQ:MACK), a $741 million market cap biotechnology company, spent a total of $467,787.60 in the company’s stock.
Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
At the moment, there are plenty of metrics investors can use to track their holdings. Two of the most under-the-radar are hedge fund and insider trading interest.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
